Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-04-23, Stock:JNJ, The news for the past five days is as follows:
2019-04-15: NEWS1: Is Johnson & Johnson Stock a Buy Ahead of Earnings?.NEWS2: Is Johnson & Johnson Stock a Buy Ahead of Earnings?.NEWS3: Noteworthy Monday Option Activity: SQ, JNJ, ZEN.NEWS4: Noteworthy Monday Option Activity: SQ, JNJ, ZEN.NEWS5: Netflix Leads The Way As Earnings Season Kicks Into Gear: Action Plan.NEWS6: Pre-Market Earnings Report for April 16, 2019 :  JNJ, BAC, UNH, BLK, PLD, PGR, CMA, FHN, WIT, MBWM.NEWS7: Pre-Market Earnings Report for April 16, 2019 :  JNJ, BAC, UNH, BLK, PLD, PGR, CMA, FHN, WIT, MBWM.NEWS8: Is Johnson & Johnson Stock a Buy Ahead of Earnings?.NEWS9: Johnson & Johnson earnings: Drug sales in focus amid worry about generic competition.NEWS10: Day Ahead: Top 3 Things to Watch.NEWS11: Health care stocks are the worst performing sector, here are the ETFs to watch.NEWS12: J&J's Erdafitinib Gets FDA Approval for Urothelial Cancer.NEWS13: J&J's Erdafitinib Gets FDA Approval for Urothelial Cancer.NEWS14: J&J's Erdafitinib Gets FDA Approval for Urothelial Cancer.NEWS15: Health Care Sector Update for 04/15/2019: ASMB, APHA, CLVS, JNJ, PFE, MRK, ABT, AMGN.NEWS16: Health Care Sector Update for 04/15/2019: ASMB, APHA, CLVS, JNJ, PFE, MRK, ABT, AMGN.NEWS17: Xtandi: A Key Oncology Pillar in 2019.NEWS18: The Future Keeps Looking Better and Better for BAX Stock.NEWS19: Diabetes drug may help against kidney disease, study finds.NEWS20: Study finds diabetes drug may prevent, slow kidney disease.NEWS21: Study finds diabetes drug may prevent, slow kidney disease.
2019-04-16: NEWS1: US halts sales of pelvic mesh tied to injuries in women.NEWS2: US halts sales of pelvic mesh tied to injuries in women.NEWS3: Johnson & Johnson (JNJ) Q1 2019 Earnings Call Transcript.NEWS4: Johnson & Johnson (JNJ) Q1 2019 Earnings Call Transcript.NEWS5: What Happened in the Stock Market Today.NEWS6: What Happened in the Stock Market Today.NEWS7: Johnson & Johnson and United Healthcare Face a Series of Obstacles.NEWS8: Qualcomm and Progressive jump while Wave Life Sciences drops.NEWS9: Stock Market News: Johnson & Johnson Reports; AT&T Parts Ways With Hulu.NEWS10: Stock Market News: Johnson & Johnson Reports; AT&T Parts Ways With Hulu.NEWS11: Johnson & Johnson Earnings: JNJ Stock Gets a Lift From Q1 Results.NEWS12: Johnson & Johnson Earnings: JNJ Stock Gets a Lift From Q1 Results.NEWS13: What Happened in the Stock Market Today.NEWS14: Johnson & Johnson (JNJ) Q1 2019 Earnings Call Transcript.NEWS15: Wall Street edges higher on generally positive earnings.NEWS16: Johnson & Johnson Posts 1st-Quarter Earnings Beat.NEWS17: Stocks close higher as Nasdaq reclaims the 8,000-mark after 6 months.NEWS18: Medical Behemoth J&J Tops Quarterly Estimates, Raises 2019 Outlook.NEWS19: Stocks End Up but UnitedHealth Weakness Slows Dow Advance.NEWS20: Markets Right Now: Stocks post modest gains on Wall Street.NEWS21: Health Care Sector Update for 04/16/2019: BSX,HUM,JNJ,RARE.NEWS22: Health Care Sector Update for 04/16/2019: BSX,HUM,JNJ,RARE.NEWS23: Banks and tech companies lead US stocks to slight gains.NEWS24: Stocks Rise but UnitedHealth Weakness Weighs on Dow.NEWS25: Nasdaq Today Tops 8000 As This FANG Nears Buy Point.NEWS26: Nasdaq Today Tops 8,000 As This FANG Nears Buy Point.NEWS27: FDA Determines Boston Scientific Hasn't Showed Reasonable Assurance Of Safety, Effectiveness For Surgical Meshes.NEWS28: Health Care Sector Update for 04/16/2019: HUM,JNJ,RARE.NEWS29: Health Care Sector Update for 04/16/2019: HUM,JNJ,RARE.NEWS30: Final trades: Qualcomm, J&J, JPMorgan, Lyft & Cisco.NEWS31: Stock Market News: Johnson & Johnson Reports; AT&T Parts Ways With Hulu.NEWS32: Stock Market News: Johnson & Johnson Reports; AT&T Parts Ways With Hulu.NEWS33: Johnson & Johnson's Legal Troubles Eat Into Earnings.NEWS34: Stocks making the biggest moves: Johnson & Johnson, Western Digital, Bank of America & more.NEWS35: J&J (JNJ) Beats on Q1 Earnings, Ups 2019 Sales Growth View.NEWS36: J&J (JNJ) Beats on Q1 Earnings, Ups 2019 Sales Growth View.NEWS37: Axsome's AXS-05 Meets Goal in Phase II Study, Shares Up.NEWS38: Axsome's AXS-05 Meets Goal in Phase II Study, Shares Up.NEWS39: Johnson & Johnson Pops Pre-Market on Earnings.NEWS40: Stocks Rise but Tumble in UnitedHealth Caps Gains.NEWS41: 2 Large Health Care Companies Announce 1st-Quarter Earnings.NEWS42: Johnson & Johnson Earnings: JNJ Stock Gets a Lift From Q1 Results.NEWS43: Stock Market News: Johnson & Johnson Reports; AT&T Parts Ways With Hulu.NEWS44: Dow Movers: UNH, JNJ.NEWS45: Dow Movers: UNH, JNJ.NEWS46: The Late Morning Rundown: April 16, 2019.NEWS47: Johnson & Johnson Stock Could Break Out on Earnings Beat.NEWS48: Markets Right Now: Indexes rise slightly on Wall Street.NEWS49: Pharmaceuticals drive J&J to better-than-expected quarterly profit.NEWS50: J&J's new ketamine-like depression drug Spravato off to 'very, very strong start,' company says.NEWS51: Market Open: April 16, 2019.NEWS52: GLOBAL MARKETS-Stocks approach new highs on positive earnings, economic data.NEWS53: J&J (JNJ) Tops Q1 Earnings; Pharma Segment Drives Sales.NEWS54: J&J (JNJ) Tops Q1 Earnings; Pharma Segment Drives Sales.NEWS55: Johnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy?.NEWS56: Johnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy?.NEWS57: Axsome's AXS-05 Meets Goal in Phase II Study, Shares Up.NEWS58: Stocks Rise but Pare Gains, Johnson & Johnson Boosts the Dow.NEWS59: J&J (JNJ) Beats on Q1 Earnings, Ups 2019 Sales Growth View.NEWS60: Johnson & Johnson Stock Is Rising Because Earnings Showed the Good ‘Far Outweighs’ the Bad.NEWS61: Q1 Earnings To Watch For.NEWS62: Global growth and stocks could be set for lift off, says UBS.NEWS63: Q1 Earnings Spigot Opens: JNJ, BAC, UNH & More.NEWS64: Stock Market Rises As These 2 Dow Jones Stocks Report Earnings.NEWS65: Johnson & Johnson (JNJ) Q1 Earnings and Revenues Top Estimates.NEWS66: Johnson & Johnson (JNJ) Q1 Earnings and Revenues Top Estimates.NEWS67: Stocks Move Higher as Johnson & Johnson Boosts the Dow.NEWS68: Stocks trading higher following strong earnings reports.NEWS69: Booming Drug Sales Rescue J&J From Gloomy Forecast.NEWS70: Health Care Sector Update for 04/16/2019: CRSP, VRTX, UNH, JNJ, PFE, ABT, MRK, AMGN.NEWS71: Health Care Sector Update for 04/16/2019: CRSP, VRTX, UNH, JNJ, PFE, ABT, MRK, AMGN.NEWS72: Markets Right Now: Health companies lead early stock gains.NEWS73: Stock Market Today Gets Lift From Dow Jones Earnings, Netflix.NEWS74: Stock Market Today Boosted By Dow Jones Earnings, Netflix.NEWS75: Johnson & Johnson Rises After Topping First-Quarter Earnings Forecasts.NEWS76: Zoetis Inc. (ZTS) Ex-Dividend Date Scheduled for April 17, 2019.NEWS77: Zoetis Inc. (ZTS) Ex-Dividend Date Scheduled for April 17, 2019.NEWS78: Johnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy?.NEWS79: Facebook Stock Falls, Johnson & Johnson Rises, and 3 More Tuesday Morning Movers.NEWS80: J&J (JNJ) Tops Q1 Earnings; Pharma Segment Drives Sales.NEWS81: US STOCKS-Wall St set to open higher on robust healthcare earnings.NEWS82: J&J profit boosted by better-than-expected pharma unit sales.NEWS83: Dow Jones Leads Stock Futures Higher; Netflix Climbs.NEWS84: Johnson & Johnson Beats Q1 Earnings Views, Lifts Revenue Outlook.NEWS85: Johnson & Johnson (JNJ) Q1 Earnings and Revenues Top Estimates.NEWS86: Watch an analyst break down Johnson & Johnson's Q1 earnings beat.NEWS87: US STOCKS-Futures rise on boost from upbeat healthcare, bank results.NEWS88: Drug sales helps Johnson & Johnson offset baby care weakness.NEWS89: J&J tops estimates on strong drug sales.NEWS90: Johnson & Johnson posts strong revenue, profit in 1Q.NEWS91: Earnings Reaction History: Johnson & Johnson, 75.0% Follow-Through Indicator, 2.4% Sensitive.NEWS92: Earnings Reaction History: Johnson & Johnson, 75.0% Follow-Through Indicator, 2.4% Sensitive.NEWS93: Netflix, Bank of America, IBM, Hulu and Notre Dame - 5 Things You Must Know.NEWS94: Johnson & Johnson's stock rises after profit and sales beat, raised sales guidance.NEWS95: Johnson & Johnson&apos;s stock rises after profit and sales beat, raised sales guidance.NEWS96: Johnson & Johnson reports first-quarter sales above expectations.NEWS97: Johnson & Johnson Reports 2019 First-Quarter Results:.NEWS98: J&J&apos;s first-quarter earnings drop 14% as legal costs soar.NEWS99: Johnson & Johnson beats first-quarter earnings, revenue estimates.NEWS100: Johnson & Johnson Reports Earnings Today. Here’s What to Expect..NEWS101: Stocks -  Bank of America, BlackRock Fall in Premarket; Netflix Rises.NEWS102: J&J Earnings, Revenue Beat in Q1.NEWS103: Netflix is already over Apple and Disney as it prepares to launch this quarter’s earnings.
2019-04-17: NEWS1: 10 Best Stocks to Buy and Hold Forever.NEWS2: 10 Best Stocks to Buy and Hold Forever.NEWS3: Stock Market News For Apr 17, 2019.NEWS4: Stock Market News For Apr 17, 2019.NEWS5: Edited Transcript of JNJ earnings conference call or presentation 16-Apr-19 12:30pm GMT.NEWS6: Liability Issues Weigh on Johnson & Johnson.NEWS7: Why The Rally In Johnson & Johnson Stock May Top Out At $150.NEWS8: Why The Rally In Johnson & Johnson Stock May Top Out At $150.NEWS9: Analysts View Johnson & Johnson's Organic Growth Guidance As Conservative.NEWS10: Stock Market News For Apr 17, 2019.NEWS11: StockBeat - UnitedHealth Deepens Losses as Fears Over Political Risk Rise.NEWS12: Health Care Sector Update for 04/17/2019: ONCS, TXMD, ABT, JNJ, PFE, MRK, AMGN.NEWS13: Health Care Sector Update for 04/17/2019: ONCS, TXMD, ABT, JNJ, PFE, MRK, AMGN.NEWS14: Is More Downside Ahead for Boeing Stock? Should You Buy?.NEWS15: Dow stock that&apos;s lost $34 billion in market cap in the last week could be a buy, says investor.NEWS16: Dow stock that's lost $34 billion in market cap in the last week could be a buy, says investor.NEWS17: 5 takeaways from Johnson & Johnson’s first-quarter results.NEWS18: Why The Rally In Johnson & Johnson Stock May Top Out At $150.NEWS19: Solid Drug Sales, Cost Control Boost Johnson & Johnson.NEWS20: Why ‘Scared’ Investors May Push Health Care Stocks Even Lower.NEWS21: Asian shares edge lower despite encouraging China GDP data.
2019-04-18: NEWS1: Be Careful With Healthcare Stocks Here.NEWS2: Checking in on trade war's impact on the markets.NEWS3: Here Are the Key Takeaways From J&J's Q1 Earnings Report.NEWS4: Here Are the Key Takeaways From J&J's Q1 Earnings Report.NEWS5: Buyer's Remorse? OTC Stock Zoom Technologies Zooms Higher Amid Potential Buyer Confusion.NEWS6: Here Are the Key Takeaways From J&J's Q1 Earnings Report.NEWS7: Health Care Sector Update for 04/18/2019: MBIO, EIGR, CGC, JNJ, PFE, ABT, MRK, AMGN.NEWS8: Health Care Sector Update for 04/18/2019: MBIO, EIGR, CGC, JNJ, PFE, ABT, MRK, AMGN.NEWS9: You can capture a dividend above 5% and still enjoy stock-market growth.NEWS10: Idorsia confirms 2019 spending plan as clinical trials "on track".
2019-04-22: NEWS1: Miguel Patricio: 10 Things to Know About the New Kraft Heinz CEO.NEWS2: Miguel Patricio: 10 Things to Know About the New Kraft Heinz CEO.NEWS3: Beauty: A Key Growth Driver of JNJ’s Consumer Segment in Q1.NEWS4: What Are Analysts Recommending for Johnson & Johnson?.NEWS5: JNJ or PFE: Comparing Legacy and Newly Launched Immunology Drugs.NEWS6: JNJ Surpassed Consensus Estimates in the First Quarter.NEWS7: Miguel Patricio: 10 Things to Know About the New Kraft Heinz CEO.NEWS8: 6 Cannabis Execs On The Strengths Of Their Businesses.NEWS9: JNJ or PFE: Comparing Their Fastest-Growing Immunology Drugs.NEWS10: JNJ or PFE: Comparing Fastest Growing Immunology Drugs.NEWS11: Health Care Sector Update for 04/22/2019: ISRG, AXGN, LLY, JNJ, PFE, ABT, MRK, AMGN.NEWS12: Health Care Sector Update for 04/22/2019: ISRG, AXGN, LLY, JNJ, PFE, ABT, MRK, AMGN.NEWS13: JNJ or PFE: Which Has Better EPS Guidance for 2019?.NEWS14: JNJ or PFE: Who has a Stronger EPS Guidance for Fiscal 2019?.NEWS15: JNJ or PFE: Who has a Stronger Revenue Guidance for Fiscal 2019?.

Answer: Rise